АNTIPHOSPHOLIPID SYNDROME AS A CAUSATIVE FACTOR IN ENDOMETRIAL FAILURE
DOI:
https://doi.org/10.47750/pnr.2022.13.S09.780Abstract
The article provides data on the results of a morphological study of early post-abortion endometrium women with antiphospholipid syndrome in the early stages of fetal loss up to 8 weeks of gestation in order to identify the causes of reproductive losses in women of the Ferghana Valley. 26 women who received treatment with low molecular weight heparin (LMWH) were analyzed, which made up group 1 and 28 women who received antiplatelet therapy pregravidally , who made up group 2.
Downloads
Published
2022-12-23 — Updated on 2022-12-23
Versions
- 2022-12-23 (2)
- 2022-12-23 (1)
How to Cite
Akhmadjonova G.M. , Negmatshaeva H.N. , Turaeva G.Yu. (2022). АNTIPHOSPHOLIPID SYNDROME AS A CAUSATIVE FACTOR IN ENDOMETRIAL FAILURE. Journal of Pharmaceutical Negative Results, 6544–6549. https://doi.org/10.47750/pnr.2022.13.S09.780
Issue
Section
Articles